ProfileGDS4132 / 241586_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 19% 17% 24% 27% 23% 25% 38% 26% 25% 28% 29% 31% 26% 19% 49% 33% 27% 21% 31% 27% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10141.976619
GSM201543Muscle PCOS pioglitazone 12131.119717
GSM201544Muscle PCOS pioglitazone 16160.064324
GSM201545Muscle PCOS pioglitazone 20171.687227
GSM201829Muscle PCOS pioglitazone 23156.259123
GSM201830Muscle PCOS pioglitazon 25159.998225
GSM201831Muscle PCOS pioglitazone 27197.328538
GSM201832Muscle PCOS pioglitazone 3163.951526
GSM201833Muscle PCOS pioglitazone 4156.129325
GSM201834Muscle PCOS pioglitazone 8166.389828
GSM201835Muscle PCOS after pioglitazone 10258.324229
GSM201836Muscle PCOS after pioglitazone 12264.82431
GSM201837Muscle PCOS after pioglitazone 16248.905626
GSM201838Muscle PCOS after pioglitazone 20235.376719
GSM201839Muscle PCOS after pioglitazone 232121.63949
GSM201840Muscle PCOS after pioglitazone 25277.515433
GSM201841Muscle PCOS after pioglitazone 27252.964427
GSM201842Muscle PCOS after pioglitazone 3235.543521
GSM201843Muscle PCOS after pioglitazone 4275.31431
GSM201844Muscle PCOS after pioglitazone 8260.353627